These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2829665)
21. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. van Oirschot JT; Gielkens AL Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645 [TBL] [Abstract][Full Text] [Related]
22. Studies on the ability of a 98-kilodalton pseudorabies virus diagnostic antigen to detect latent infections induced by low-dose exposure to the virus. McGinley MJ; Platt KB Am J Vet Res; 1988 Sep; 49(9):1489-93. PubMed ID: 2851953 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs. Mengeling WL; Brockmeier SL; Lager KM Arch Virol; 1994; 134(3-4):259-69. PubMed ID: 8129615 [TBL] [Abstract][Full Text] [Related]
24. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs. Bouma A; De Jong MC; Kimman TG Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236 [TBL] [Abstract][Full Text] [Related]
25. Growth properties and vaccine efficacy of recombinant pseudorabies virus defective in glycoprotein E and thymidine kinase genes. Wu CY; Liao CM; Chi JN; Chien MS; Huang C J Biotechnol; 2016 Jul; 229():58-64. PubMed ID: 27164258 [TBL] [Abstract][Full Text] [Related]
26. [Construction and characterization of a pseudorabies virus TK-/gG- mutant]. Xu XJ; Xu GY; Chen HC; Liu ZF; He QG Sheng Wu Gong Cheng Xue Bao; 2004 Jul; 20(4):532-5. PubMed ID: 15968983 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine. Swenson SL; McMillen J; Hill HT J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983 [TBL] [Abstract][Full Text] [Related]
28. Circumvention of maternal antibody interference by immunization of newborn pigs with glycoprotein gIII-deleted marker vaccine. Kit S; McConnell S; Kit M; Lawhorn B Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():421-30. PubMed ID: 8270271 [TBL] [Abstract][Full Text] [Related]
29. An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine. Qian P; Li XM; Jin ML; Peng GQ; Chen HC Vaccine; 2004 Jun; 22(17-18):2129-36. PubMed ID: 15149769 [TBL] [Abstract][Full Text] [Related]
30. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge. Hu RM; Zhou Q; Song WB; Sun EC; Zhang MM; He QG; Chen HC; Wu B; Liu ZF Vaccine; 2015 Oct; 33(43):5733-5740. PubMed ID: 26428456 [TBL] [Abstract][Full Text] [Related]
31. The response of pigs inoculated with a thymidine kinase-negative (TK-) pseudorabies virus to challenge infection with virulent virus. Ferrari M; Gualandi GL; Corradi A; Monaci C; Romanelli MG; Losio MN; Cantoni AM; Pratelli A Comp Immunol Microbiol Infect Dis; 2000 Jan; 23(1):15-26. PubMed ID: 10660255 [TBL] [Abstract][Full Text] [Related]
32. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659 [TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes. Wang J; Song Z; Ge A; Guo R; Qiao Y; Xu M; Wang Z; Liu Y; Zheng Y; Fan H; Hou J BMC Vet Res; 2018 Sep; 14(1):287. PubMed ID: 30241529 [TBL] [Abstract][Full Text] [Related]
34. A study of the ability of a TK-negative and gI/gE-negative pseudorabies virus (PRV) mutant inoculated by different routes to protect pigs against PRV infection. Ferrari M; Brack A; Romanelli MG; Mettenleiter TC; Corradi A; Dal Mas N; Losio MN; Silini R; Pinoni C; Pratelli A J Vet Med B Infect Dis Vet Public Health; 2000 Dec; 47(10):753-62. PubMed ID: 11204130 [TBL] [Abstract][Full Text] [Related]
35. Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins. Dory D; Torché AM; Béven V; Blanchard P; Loizel C; Cariolet R; Jestin A Vaccine; 2005 May; 23(26):3483-91. PubMed ID: 15837372 [TBL] [Abstract][Full Text] [Related]
36. Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E. Firkins LD; Weigel RM; Biehl LG; Hahn EC Am J Vet Res; 1997 Sep; 58(9):976-84. PubMed ID: 9285001 [TBL] [Abstract][Full Text] [Related]
37. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes. Ferrari M; Mettenleiter TC; Romanelli MG; Cabassi E; Corradi A; Dal Mas N; Silini R J Comp Pathol; 2000; 123(2-3):152-63. PubMed ID: 11032669 [TBL] [Abstract][Full Text] [Related]
38. Inoculation of pigs with Streptococcus suis type 2 alone or in combination with pseudorabies virus. Iglesias JG; Trujano M; Xu J Am J Vet Res; 1992 Mar; 53(3):364-7. PubMed ID: 1317689 [TBL] [Abstract][Full Text] [Related]
39. Protection of mice and swine from pseudorabies virus-induced mortality by administration of pseudorabies virus-specific mouse monoclonal antibodies. Marchioli C; Yancey RJ; Timmins JG; Post LE; Young BR; Povendo DA Am J Vet Res; 1988 Jun; 49(6):860-4. PubMed ID: 2840843 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1. Mikulska-Skupień E; Szweda W; Procajło Z Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]